- Home
- AMWL vs PROK Comparison
AMWL vs PROK Comparison
Compare AMWL & PROK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AMWL
- PROK
- Stock Information
- Founded
- AMWL 2006
- PROK 2015
- Country
- AMWL United States
- PROK United States
- Employees
- AMWL N/A
- PROK N/A
- Industry
- AMWL Retail: Computer Software & Peripheral Equipment
- PROK Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- AMWL Technology
- PROK Health Care
- Exchange
- AMWL Nasdaq
- PROK Nasdaq
- Market Cap
- AMWL 121.9M
- PROK 94.9M
- IPO Year
- AMWL 2020
- PROK N/A
- Fundamental
- Price
- AMWL $6.94
- PROK $0.70
- Analyst Decision
- AMWL Hold
- PROK Buy
- Analyst Count
- AMWL 6
- PROK 4
- Target Price
- AMWL $10.00
- PROK $5.00
- AVG Volume (30 Days)
- AMWL 59.7K
- PROK 1.2M
- Earning Date
- AMWL 05-01-2025
- PROK 05-16-2025
- Dividend Yield
- AMWL N/A
- PROK N/A
- EPS Growth
- AMWL N/A
- PROK N/A
- EPS
- AMWL N/A
- PROK N/A
- Revenue
- AMWL $261,675,000.00
- PROK $76,000.00
- Revenue This Year
- AMWL $2.28
- PROK N/A
- Revenue Next Year
- AMWL $10.06
- PROK N/A
- P/E Ratio
- AMWL N/A
- PROK N/A
- Revenue Growth
- AMWL 2.79
- PROK N/A
- 52 Week Low
- AMWL $5.00
- PROK $0.46
- 52 Week High
- AMWL $12.95
- PROK $4.44
- Technical
- Relative Strength Index (RSI)
- AMWL 46.28
- PROK 41.42
- Support Level
- AMWL $6.42
- PROK $0.94
- Resistance Level
- AMWL $7.15
- PROK $0.77
- Average True Range (ATR)
- AMWL 0.59
- PROK 0.12
- MACD
- AMWL 0.01
- PROK -0.01
- Stochastic Oscillator
- AMWL 42.79
- PROK 17.63
About AMWL American Well Corporation
American Well Corp is a telehealth company enabling digital delivery of care for its customers. Its platform, Amwell, digital care delivery solution that equips health systems, health plans, government, and innovator clients with the tools to enable new models of care for their patients and members enabling care delivery across the full healthcare continuum - from primary and urgent care in the home to high acuity specialty consults, such as telestroke and telepsychiatry, in the hospital. It provides both on-demand and scheduled consultations. Its Health Plan Programs include Virtual Primary Care, Musculoskeletal Care, Dermatology Care, and Chronic Care among others.
About PROK ProKidney Corp.
ProKidney Corp is a clinical-stage biotechnology company with a transformative proprietary cell therapy platform capable of treating multiple chronic kidney diseases using a patient's cells isolated from the patient intended for treatment. Its product candidate, REACT (Renal Autologous Cell Therapy) is a disease-modifying cell therapy made from a patient's renal cells. REACT has the potential to slow and stabilize the progression of chronic kidney disease. The company's pipeline consists of the development program for severe diabetic kidney disease.